#VisualAbstract: Pemafibrate does not reduce cardiovascular risk in patients with type 2 diabetes and elevated triglycerides
Click here to read this study in NEJM.
Read More
studygraphics
#VisualAbstract: Timing of daily antihypertensives does not change cardiovascular outcomes
1. The primary composite cardiovascular endpoint was similar among patients in the evening and...
Read More
#VisualAbstract: Methylprednisolone prophylaxis for cardiac surgery in infants with congenital heart disease does not improve outcomes
Click here to read this paper in NEJM.
Read More
#VisualAbstract: COVID-19 vaccination is safe during pregnancy and has benefits for neonatal outcomes
1. In a systematic review with meta-analysis, COVID-19 vaccination during pregnancy was associated...
Read More
#VisualAbstract: Continuous glucose monitoring in type 1 diabetes results in improved blood glucose levels
1. In patients with type 1 diabetes, using intermittently scanned continuous glucose monitoring...
Read More
#VisualAbstract: Continued enzalutamide after progression of metastatic prostate cancer improves progression-free survival
1. The median progression-free survival was higher in the enzalutamide vs the placebo group (9.5...
Read More
#VisualAbstract: Ivermectin does not improve recovery time in adults with mild to moderate COVID-19 infection
Click here to read this study in JAMA.
Read More
#VisualAbstract: Endovascular thrombectomy improves functional outcomes in adults with basilar-artery occlusions
1. In comparison to the best available medical care, a greater proportion of patients with...
Read More
#VisualAbstract: Higher mean arterial blood pressure targets did not improve outcomes in comatose survivors of cardiac arrest
Click here to read this study in NEJM.
Read More
#VisualAbstract: Adjunctive D-Cycloserine for transcranial magnetic stimulation can improve treatment-resistant depressive symptoms
Click here to read this study in JAMA Psychiatry.
Read More
#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma
Click to read this study in JAMA Otolaryngology – Head & Neck...
Read More
#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer
1. Pembrolizumab-alone or pembrolizumab-chemotherapy prolonged overall survival vs...
Read More
#VisualAbstract: Rituximab plus lenalidomide shows comparable survival compared to chemotherapy for CD20⁺ follicular lymphoma
Click to read this study in the Journal of Clinical Oncology.
Read More
#VisualAbstract: Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma
1. 4-year recurrence-free survival was significantly higher with nivolumab plus ipilimumab...
Read More
#VisualAbstract: Neoadjuvant atezolizumab is not effective for node-positive HER2⁺ breast cancer
Click to read this study in the Journal of Clinical Oncology.
Read More
#VisualAbstract: Cefepime/enmetazobactam superior to piperacillin/tazobactam for the treatment of complicated urinary tract infections and acute pyelonephritis
1. In this randomized controlled trial, treatment of acute pyelonephritis and complicated urinary...
Read More
#VisualAbstract: Asundexian does not reduce the risk of recurrent strokes after non-cardioembolic ischemic stroke
1. The composite of MRI-detected brain infarcts and symptomatic ischemic stroke was comparable...
Read More
#VisualAbstract: Dapagliflozin slows disease progression in patients with heart failure with preserved ejection fraction
1. Dapagliflozin was shown to reduce the risk of disease progression and cardiovascular death in...
Read More